Further, the administration of C3a in the subacute phase post-stroke promoting functional recovery by stimulating astrocyte-derived IGF-1, suggests a dose- and context-dependent protective role for C3aR signaling during recovery [20]. The gene discussed is C3AR1; the disease is Stroke.